CN1966000A - Chinese medicinal formulation for treating pulmonary tuberculosis - Google Patents
Chinese medicinal formulation for treating pulmonary tuberculosis Download PDFInfo
- Publication number
- CN1966000A CN1966000A CN 200610051259 CN200610051259A CN1966000A CN 1966000 A CN1966000 A CN 1966000A CN 200610051259 CN200610051259 CN 200610051259 CN 200610051259 A CN200610051259 A CN 200610051259A CN 1966000 A CN1966000 A CN 1966000A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- treatment
- pulmonary tuberculosis
- medicine
- phthisical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000008128 pulmonary tuberculosis Diseases 0.000 title abstract description 25
- 239000000203 mixture Substances 0.000 title description 6
- 238000009472 formulation Methods 0.000 title description 2
- 239000003814 drug Substances 0.000 claims abstract description 72
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 14
- 239000002775 capsule Substances 0.000 claims abstract description 13
- 239000006187 pill Substances 0.000 claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 241000242759 Actiniaria Species 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000007670 refining Methods 0.000 claims 1
- 241001175275 Anemone davidii Species 0.000 abstract 1
- 241001313855 Bletilla Species 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 241000218229 Humulus japonicus Species 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 6
- 239000003172 expectorant agent Substances 0.000 description 6
- 230000003419 expectorant effect Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 5
- 206010029410 night sweats Diseases 0.000 description 5
- 230000036565 night sweats Effects 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 201000008827 tuberculosis Diseases 0.000 description 4
- 241000233855 Orchidaceae Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 230000000973 chemotherapeutic effect Effects 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 208000030208 low-grade fever Diseases 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000008203 tachypnea Diseases 0.000 description 3
- 206010043089 tachypnoea Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241001083548 Anemone Species 0.000 description 1
- 241001313857 Bletilla striata Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241001250598 Pleione bulbocodioides Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 108010052008 colla corii asini Proteins 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 229960005206 pyrazinamide Drugs 0.000 description 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a Chinese medicinal preparation for treating phthisis which is prepared from Anemone davidii Franch. 30-50, bletilla tuber 25-35, humulus scandens merr 15-25 and gingko leaf 10-15 through conventional methods of medicine production. The medicament can be prepared into powders, capsules and pills.
Description
Technical field
Patent of the present invention relates to a kind of Chinese medicine preparation, relates in particular to the phthisical Chinese medicine preparation of a kind of treatment.
Background technology
Pulmonary tuberculosis is to have communicable pulmonary chronic, weak property illness, is commonly encountered diseases, frequently-occurring disease, ancient claim " pulmonary tuberculosis ", and symptom was its basic feature with " cough, spitting of blood, hectic fever, night sweat, become thin ", to mankind's harm more thousand.Because the appearance of chemotherapeutics, this disease was once once controlled, and in the last few years, because the generation of the Resistant strain of pulmonary tuberculosis pathogenic bacteria makes this ancient disease revivable again, according to the preliminary statistics, China's number of patients every year was with 1% speed increment.Analyze its reason, as the phthisical medicine of treatment in the prior art mainly is streptomycin, isoniazid, pyrazinamide, rifampicin etc., these medicines are big to the toxicity of accepting pulmonary tuberculosis treatment patient, the patient who has is the toxicity that can not tolerate Western medicine, and be interrupted, interrupt or drug withdrawal voluntarily, what have then is can not or to be reluctant to obey Western medicine because of the disease of liver or other system, but observing of many patient's strictnesses also the arranged principle of medication of " early stage; an amount of; rule; associating; whole process " of doctor trained in Western medicine chemotherapeutic, but still can not thoroughly cure the result of the generation of the morbific Resistant strain of pulmonary tuberculosis that Here it is.In recent years this phenomenon is known through research is clear in medical circle, tuberculosis is divided A, B, four kinds of floras of C, D, A group's metabolism is vigorous, easily killed by chemotherapeutic, B, C group's poor metabolism, be difficult for being killed by chemotherapeutic, D group is in static resting state, chemotherapy is inoperative, can only rely on immune function of human body and control, the patient of immunologic hypofunction, its phagocyte can not be eliminated intracellular tulase effectively, form granulomatous lesion, this infected macrophage not only can not be eliminated infectious bacteria, infects flora on the contrary at its growth and breeding.Can prove that by above immunity is the key point that human body is defeated tuberculosis.So when adopting drug treatment, because the generation of Resistant strain in recent years, what display is that therapeutic effect is not remarkable, add medicine-feeding valency height, the rural area has many people cannot afford to consult a doctor, and can not eat many-sided reason such as medicine and makes and patient's number of this disease rise year by year.
For to various pneumonopathy or phthisical treatment aspect, in motherland's traditional Chinese medical science treasure-house, many prescriptions and proved recipe are arranged, introducing the phthisical Chinese medicine of a kind of treatment as application number CN99116345.1 title " the phthisical Chinese medicine of a kind of treatment ", mainly is drawbacks such as costing an arm and a leg of overcoming that existing Western medicine exists, toxic side effect, curative effect be relatively poor.The prescription that it includes has the Radix Stemonae, Bulbus Lilii, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Platycodonis, Radix Polygalae, Fructus Mori, the Radix Astragali, Rhizoma Polygonati, Fructus Lycii, Radix Curcumae, Semen Nelumbinis, longan pulp, Radix Ophiopogonis, Radix Asparagi, Radix Codonopsis, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Rhizoma Imperatae, Colla Corii Asini, Herba Houttuyniae, Cordyceps, Gecko, Radix Glycyrrhizae.Be mainly used in treatment pulmonary tuberculosis and pulmonary cavity, also can treat bronchiectasis, diseases such as spitting of blood, tuberculosis of breast, lymphoid tuberculosis.Application number is arranged in addition for the CN98123926.9 name is called " Chinese herbal medicine of treatment pulmonary tuberculosis ", application number is called " the phthisical Chinese medicine of a kind of treatment ", application number CN00112927.9 for the CN98115357.7 name, name is called " the phthisical Chinese herbal medicine of a kind of treatment " patent and has also introduced the application of some treatment pulmonary tuberculosis.
The present invention seeks to develop one and be exclusively used in the phthisical Chinese medicine preparation of treatment, require the good absorbing of this medicine, easy to carry, expense is lower, the cure rate height, have no side effect, on the basis of inheriting former generation's proved recipe, study for a long period of time through the inventor, by the practice of self, constantly sum up and innovation, invented the phthisical Chinese medicine preparation of this special for treating, be mainly powder, capsule, pill.
Summary of the invention
Below be concrete summary of the invention,
The phthisical Chinese medicine preparation of a kind of treatment, the composition of its medicine is that the prescription by mass ratio is a Rhizoma anemones davidii 30～50: Pseudobulbus Bletillae (Rhizoma Bletillae) 25～35: Herba humuli scandentis 15～25: Herba Bulbophylli Odoratissim 10～15, the phthisical Chinese medicine preparation of this treatment can be made according to the conventional production method of Chinese medicine patent medicine, above the indication Chinese medicine preparation mean powder, capsule, pill.
More than treat phthisical Chinese medicine preparation, the composition mass ratio of its medicine is a Rhizoma anemones davidii 40: Pseudobulbus Bletillae (Rhizoma Bletillae) 30: Herba humuli scandentis 20: Herba Bulbophylli Odoratissim 10.
More than treat phthisical Chinese medicine preparation, the manufacture method of its powder, pill, capsule is with its pulverize separately of each medicine, be ground into fine powder, sieve, then according to its composition quality than Rhizoma anemones davidii 30～50: Pseudobulbus Bletillae (Rhizoma Bletillae) 25～35: Herba humuli scandentis 15～25: Herba Bulbophylli Odoratissim 10～15, weighing respectively, uniform mixing, packing promptly obtain powder; On the powder basis, promptly get capsule, powder is added distilled water, adjuvant commonly used make the ball shape and pack and promptly obtain pill with capsulation.
The treatment pulmonary tuberculosis must be abideed by the doctor's advice prescription and take medicine, or/1～3 skies of general 3～6 grams of being grown up, and the children amount is the adult's 1/2nd.
Below the Chinese medicine of medicine composition is in the present invention done some introductions:
Rhizoma anemones davidii: another name, Rhizoma seu herba Asystasiellae Chinensis connects, red synthetism connects, starve tiger, ZUANGUFENG, blood crow etc.Be ranunculaceae plant southwest Anemone cathayensis Kitag. rhizome and leaf.Plant is a perennial herb, and is high about 40～60 centimetres.Nature and flavor: bitter, warm.Function cures mainly: invigorate blood circulation, pain relieving, detumescence, detoxify, control traumatic injury, rheumatalgia, aphtha, furunculosis of the buttock." Chinese medicine voluminous dictionary " 1985.5 months the 1st edition.P2163.
Pseudobulbus Bletillae (Rhizoma Bletillae): another name, the Pseudobulbus Bletillae (Rhizoma Bletillae), sweet, Bletilla striata (Thunb.ex A.Murray)Rchb.f., pleionebulbocodioides rolfe, white clam.Tuber for the orchid Pseudobulbus Bletillae (Rhizoma Bletillae).Perennial herb, about 30～70 centimetres of Gao Keda.Nature and flavor: bitter sweet, cool.Go into lung meridian.Function cures mainly: tonifying the lung, hemostasis, detumescence, granulation promoting, hold back skin ulcer.Control lung and hinder hemoptysis, epistaxis, diseases such as ulcer sore pain." Chinese medicine voluminous dictionary " 1985.5 months the 1st edition.P667.
Herba Bulbophylli Odoratissim: different name stone string orchid.Be orchid Herba Bulbophylli inconspicui and congener, the perennial evergreen draft, happiness is given birth on rock seam or the tree, all herbal medicine.Nature and flavor: sweet light, cool.Function cures mainly: moistening the lung and resolving phlegm, promoting the circulation of QI to relieve pain.Control pulmonary tuberculosis, spitting of blood, chronic tracheitis, chronic pharyngitis, hernia pain etc." Chinese medicine voluminous dictionary " 1985.5 months the 1st edition.P1361.
Herba humuli scandentis; Different name is reined in grass, Ge Leman, Caulis Momordicae Charantiae, is drawn rattan etc.Herb for the moraceae plants Herba humuli scandentis.Be annual or perennial climing property draft, long number rice has barb perverse, and leaf is to life.Nature and flavor: sweet in the mouth is nontoxic.Function cures mainly: clearing away heat and promoting diuresis, gonorrhea is controlled in repercussive, detoxifcation, dysuria. malaria, diarrhoea, dysentery, pulmonary tuberculosis, lung abscess, pneumonia etc." Chinese medicine voluminous dictionary " 1985.5 months the 1st edition.P2313.
Above Chinese medicine is for stating clearly avirulence on " Chinese medicine voluminous dictionary " 1985.5 months the 1st edition.
The crude drug source of Chinese medicine preparation of the present invention is wide, and lower, the good absorbing of expense is easy to carry, is convenient to preserve, and the cure rate height has no side effect.This side possesses general adaptability.This medication journey was generally 3～9 months, and the minority refractory pulmonary tuberculosis is arranged, and reached 12 months most, was everlasting and took effect about two weeks, in 102 examples of clinical treatment, cured 96 examples, accounted for 94.1%, and 6 examples that take a turn for the better account for 5.9%, in the clinical trial, did not have invalid case.
The present invention is the phthisical Chinese medicine preparation of a kind of treatment, can be applicable to various pneumonopathy, phthisical treatment, prove through former generation and inventor's clinical practice for many years, compare with the treatment pneumonopathy of other types, phthisical Chinese and western drugs, this medicine has no side effect to the medication person, and has curative effect certainly, and the time of medicine for treatment is shorter, instant effect, the characteristics of the price cheapness of medicine.Simultaneously, the inventor carried out research and practice, the taboo of taking of having found out this medicine according to the property of medicine, the pharmacology of used Chinese medicine, when this Chinese medicine preparation is taken, be not taken by pregnant women, avoid edible living, cold, pungent group food, prohibit and drink, smoke, have a rest to avoid producing disadvantageous physiological metabolism reaction more.
The specific embodiment
Embodiment, with Rhizoma anemones davidii, Pseudobulbus Bletillae (Rhizoma Bletillae), Herba humuli scandentis, Herba Bulbophylli Odoratissim pulverize separately be fine powder to sieving, get Rhizoma anemones davidii 400g, Pseudobulbus Bletillae (Rhizoma Bletillae) 300g, Herba humuli scandentis 200g, Herba Bulbophylli Odoratissim 100g, divide pouch-packaged behind the uniform mixing, promptly obtain powder; On the powder basis, promptly get capsule with capsulation, with powder add suitable distilled water, adjuvant commonly used can be made watered pill shape or honey pill agent, row packing again, the pulmonary tuberculosis medicine just can obtain medical treatment.The treatment pulmonary tuberculosis must be abideed by the doctor's advice prescription and take medicine, powder/1～3 skies of general 3～5 grams of being grown up, and the children amount is 1/2nd of adult's amount, pill is according to the relatively more definite dosage of manufacturing specification.
Clinical case is to the explanation of curative effect of the present invention:
For many years, on the basis of inheriting former generation and inventor's clinical practice for many years, carry out statistical analysis when adopting above-mentioned Chinese medicine preparation to treat to the many cases person of seeing a doctor who accepts for medical treatment, based on capsule and pill, 102 routine pulmonary tuberculosis patients are treated obtain notable therapeutic effect, also carried out observing and following up a case by regular visits to later on to treating patient, existing with summary of interrelated data do.Amount to the patient who cures and produce effects is arranged, cure rate is about more than 94%.
Clinical data
1, patient's type: comprehensive case 102 examples, primary pulmonary tuberculosis 12 examples, infiltrative type 55 examples, chronic fibrotic cavitys type 25 examples, 10 examples are other types, wherein infiltrative type is maximum.
2, diagnosis basis: according to medical history, clinical symptoms, sign, chemical examination and X ray examination are made a definite diagnosis.Difficult patient still needs and does further to check by B ultrasonic, CT.
3, previously treat history: this organizes 102 examples, and the diagnosis and treatment patient substantially makes a definite diagnosis and treated at large hospital, once regular chemotherapy person's 35 examples, irregular chemotherapy person's 66 examples.
4, Therapeutic Method:
Based on capsule and pill, some patients are generally 6～JIUYUE the course of treatment, small number of patients can extend to 12 months.
5, curative effect determinate standard
Decide according to " the disease therapeuticing effect evaluation criteria " of Ministry of Public Health formulation in 1981:
The A recovery from illness: clinical symptom disappearance, expectorant tulase continue feminine gender and reach more than 1 year, and the conducting lung X-ray examination performance belongs to the inactivity focus, and follow-up observation did not still have activeness more than 1 year.
B takes a turn for the better: possess a following person, the more preceding absorption of pathological changes takes a turn for the better, and the cavity dwindles closure, and the expectorant tulase reduces or turns out cloudy.
C is invalid: expectorant bacterium and X ray examination, all do not have the changer before and after the treatment.
Therapeutic outcome: comprehensive case 102 examples, cure 96 examples, account for 94.1%, 6 examples that take a turn for the better account for 5.9%, and the course of treatment is the shortest 3 months, and is the longest 12 months, follow-up observation 1～2 year.
Now curing case with regard to some is set forth in down:
Case 1, Deng, the man, 40 years old, suffer from " cavernous pulmonary tuberculosis ", once about half a year, failed all the time to cure before 2004 at Liuzhi Special Region hospital regular treatment, after be interrupted again and take medicine, the state of an illness increases the weight of gradually, liver function damage.So change the request treatment by Chinese herbs, the inventor takes capsule of the present invention to him, patient's cough after February, tachypnea, sputum mixed with blood, chest pain, night sweat symptom show and subtract, low grade fever is eliminated, and the more preceding improvement of diet is imitated more not square, the patient continues to take this medicine, all disappears through 3 months all symptoms.Repeatedly film making proof pulmonary tuberculosis is all fully recovered, and liver function has been recovered normally, follows up a case by regular visits to 2 years rabat, expectorant and cultivates no abnormality seen.
Case 2 is revived certain, the man, 25 years old, the peasant suffered from " fibro-cavitative pulmonary tuberculosis " and once crossed some months at hospital's regular treatment before 2004, after again from obeying traditional herbal medicine, the state of an illness fails to cure all the time, often cough, spitting of blood, chest pain, night sweat, spirit and appetite are very poor, general weakness arrives the inventor place upon somebody's introduction, takes capsule of the present invention, after 3 months, the patient has cough when removing, and above-mentioned symptom disappears substantially, checks empty the reparation through film making, calcification has appearred, medicine takes effect, after 6 months, and patient's disappearance of coughing, have rosy cheeks, spirit and diet are very good, followed up a case by regular visits to patient's rabat 1 year, expectorant is cultivated normal always.
Case 3, Zhu, man, 32 years old, married, suffer from " cavernous pulmonary tuberculosis ", once in the diagnosis and treatment of Liuzhi Special Region hospital, failed about 1 year to cure before 2005, its interruption is taken medicine, the state of an illness increases the weight of gradually, asks treatment by Chinese herbs so change, and the inventor takes capsule of the present invention to him, patient's cough behind the first quarter moon, tachypnea, sputum mixed with blood, chest pain, night sweat symptom show and subtract, low grade fever is eliminated, the more preceding improvement of diet, and the patient continues to take this medicine, process all symptoms half a year all disappear, the pulmonary tuberculosis of repeatedly making film is all fully recovered, and liver function has been recovered normally to follow up a case by regular visits to no abnormality seen half a year.
Case 4, leaf, man, 50 years old, the peasant suffers from " infiltrative pulmonary tuberculosis ", before 2002 once in the Puding County hospitalize about 1 year, fail to cure, after be interrupted again and take medicine, the state of an illness increases the weight of gradually, the people introduces and finds the inventor, and the inventor takes capsule of the present invention after giving his diagnosis and treatment, patient's cough after 1 month, tachypnea, sputum mixed with blood, chest pain, night sweat symptom show and subtract, and low grade fever is eliminated, the more preceding improvement of diet, through adjusting dose, the patient continues to take this medicine, all disappears through all symptoms of some months.The pulmonary tuberculosis of repeatedly making film is all fully recovered, and follows up a case by regular visits to through 1 year and does not see rabat, expectorant cultivation unusually.
Claims (3)
1, the phthisical Chinese medicine preparation of a kind of treatment, it is characterized in that preparation is that prescription by mass ratio is a Rhizoma anemones davidii 30～50: Pseudobulbus Bletillae (Rhizoma Bletillae) 25～35: Herba humuli scandentis 15～25: Herba Bulbophylli Odoratissim 10～15, the phthisical Chinese medicine preparation of this treatment can be made according to the conventional production method of Chinese medicine patent medicine.
2, the phthisical Chinese medicine preparation of a kind of treatment according to claim 1 is characterized in that the prescription of its Chinese medicine preparation is a Rhizoma anemones davidii 40 by mass ratio: Pseudobulbus Bletillae (Rhizoma Bletillae) 30: Herba humuli scandentis 20: Herba Bulbophylli Odoratissim 10.
3, the phthisical Chinese medicine preparation of a kind of treatment according to claim 1 is characterized in that wherein production method is to make according to the conventional production method of Chinese medicine patent medicine, above the agent of obtaining through refining mean Chinese medicine for oral administration powder, capsule, pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100512594A CN100448472C (en) | 2006-10-30 | 2006-10-30 | Chinese medicinal formulation for treating pulmonary tuberculosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100512594A CN100448472C (en) | 2006-10-30 | 2006-10-30 | Chinese medicinal formulation for treating pulmonary tuberculosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1966000A true CN1966000A (en) | 2007-05-23 |
| CN100448472C CN100448472C (en) | 2009-01-07 |
Family
ID=38075093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100512594A Expired - Fee Related CN100448472C (en) | 2006-10-30 | 2006-10-30 | Chinese medicinal formulation for treating pulmonary tuberculosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100448472C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104998071A (en) * | 2015-07-02 | 2015-10-28 | 贵阳中医学院 | Compound preparation ofherb of dense flower Bulbophyllum and preparation and detection method for said compound preparation |
| CN105412379A (en) * | 2015-12-09 | 2016-03-23 | 刘传新 | Inhalation-type phthisis treatment preparation and preparing method thereof |
| CN107714940A (en) * | 2017-10-12 | 2018-02-23 | 汪昔林 | One kind treats phthisical Chinese medicine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1386535A (en) * | 2002-06-11 | 2002-12-25 | 范忠智 | Medicine for treating tuberculosis |
-
2006
- 2006-10-30 CN CNB2006100512594A patent/CN100448472C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104998071A (en) * | 2015-07-02 | 2015-10-28 | 贵阳中医学院 | Compound preparation ofherb of dense flower Bulbophyllum and preparation and detection method for said compound preparation |
| CN105412379A (en) * | 2015-12-09 | 2016-03-23 | 刘传新 | Inhalation-type phthisis treatment preparation and preparing method thereof |
| CN107714940A (en) * | 2017-10-12 | 2018-02-23 | 汪昔林 | One kind treats phthisical Chinese medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100448472C (en) | 2009-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100457176C (en) | Chinese medicinal preparation for curriculum of physical and fatigue reducing | |
| CN112022929A (en) | Traditional Chinese medicine composition for treating diabetic peripheral neuropathy and preparation method thereof | |
| CN101773632B (en) | Chinese medicine composition for treating dizziness and preparation method thereof | |
| CN104784505A (en) | Dendrobium officinale healthcare product with auxiliary blood glucose reducing function and preparation method thereof | |
| CN104013756A (en) | Traditional Chinese medicine composition for preventing and treating diarrhea and application of traditional Chinese medicine composition | |
| CN101530579B (en) | A pharmaceutical composition for soothing the nerves | |
| CN1055008C (en) | Chinese herbal medicine for treating thyreoidism | |
| CN1679661A (en) | Medicine for treating female mazoplasia and preparation thereof | |
| CN103263531A (en) | Chinese medicine composition for treating prosopalgia and preparation method thereof | |
| CN102861199A (en) | Traditional Chinese medicine composition for treating gastroesophageal reflux disease and preparation method | |
| CN1294015A (en) | Medicine for treating thyroid enlargement and thyroidism | |
| CN100448472C (en) | Chinese medicinal formulation for treating pulmonary tuberculosis | |
| CN1191847C (en) | Medicated pillow and its making process | |
| CN1181880C (en) | Compound macrostem onion preparation for curing chronic obstructive lung disease and its preparing method | |
| CN108635457A (en) | A kind of Chinese medicine composition and the preparation method and application thereof for treating constipation | |
| CN1872308B (en) | Preparation of Chinese traditional medicine for treating pulmonary tuberculosis | |
| CN1081464C (en) | Chinese medicine for acute and chronic diarrhea, dysentery with purulent and bloody stools, as well as acute and chronic colitis | |
| CN108159257A (en) | Treat Chinese medicine composition of chronic enteritis and preparation method thereof | |
| CN1269518C (en) | Compound medicine for treating tuberculosis and its preparing method | |
| CN117959390B (en) | A traditional Chinese medicine composition for treating long-term symptoms after novel coronavirus infection, its preparation method and application. | |
| CN100446789C (en) | Traditional Chinese medicine pill for clearing toxin of pneumonia | |
| CN103110743B (en) | Traditional Chinese medicine composition for treating or preventing neurasthenia and preparation method thereof | |
| CN101884762B (en) | Traditional Chinese medicine for treating emphysema | |
| CN1954841B (en) | Medicine for treating chronic pharyngitis | |
| CN104606553B (en) | A medicinal composition for treating postpartum blood deficiency fever |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090107 Termination date: 20141030 |
|
| EXPY | Termination of patent right or utility model |